Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 7 de 7
Filtrer
1.
Am J Respir Crit Care Med ; 210(4): 435-443, 2024 Aug 15.
Article de Anglais | MEDLINE | ID: mdl-38484130

RÉSUMÉ

Rationale: Idiopathic pulmonary fibrosis is a fatal and progressive disease with limited treatment options. Objectives: We sought to assess the efficacy and safety of CC-90001, an oral inhibitor of c-Jun N-terminal kinase 1, in patients with idiopathic pulmonary fibrosis. Methods: In a Phase 2, randomized (1:1:1), double-blind, placebo-controlled study (ClinicalTrials.gov ID: NCT03142191), patients received CC-90001 (200 or 400 mg) or placebo once daily for 24 weeks. Background antifibrotic treatment (pirfenidone) was allowed. The primary endpoint was change in the percentage of predicted FVC (ppFVC) from baseline to Week 24; secondary endpoints included safety. Measurements and Main Results: In total, 112 patients received at least one dose of study drug. The study was terminated early because of a strategic decision made by the sponsor. Ninety-one patients (81%) completed the study. The least-squares mean changes from baseline in ppFVC at Week 24 were -3.1% (placebo), -2.1% (200 mg), and -1.0% (400 mg); the differences compared with placebo were 1.1% (200 mg; 95% confidence interval: -2.1, 4.3; P = 0.50) and 2.2% (400 mg; 95% confidence interval: -1.1, 5.4; P = 0.19). Adverse event frequency was similar in patients in the combined CC-90001 arms versus placebo. The most common adverse events were nausea, diarrhea, and vomiting, which were more frequent in patients in CC-90001 arms versus placebo. Fewer patients in the CC-90001 arms than in the placebo arm experienced cough and dyspnea. Conclusions: Treatment with CC-90001 over 24 weeks led to numerical improvements in ppFVC in patients with idiopathic pulmonary fibrosis compared with placebo. CC-90001 was generally well tolerated, which was consistent with previous studies. Clinical trial registered with www.clinicaltrials.gov (NCT03142191).


Sujet(s)
Fibrose pulmonaire idiopathique , Humains , Fibrose pulmonaire idiopathique/traitement médicamenteux , Fibrose pulmonaire idiopathique/physiopathologie , Méthode en double aveugle , Mâle , Femelle , Sujet âgé , Adulte d'âge moyen , Résultat thérapeutique , JNK Mitogen-Activated Protein Kinases/antagonistes et inhibiteurs , Adulte
2.
Genet Mol Res ; 6(1): 50-8, 2007 Feb 15.
Article de Anglais | MEDLINE | ID: mdl-17469054

RÉSUMÉ

The purpose of the present study was to determine the effects of the steroidal plant hormone, 24-epibrassinolide (BL), on the mitotic index and growth of onion (Allium cepa) root tips. The classical Allium test was used to gather and quantify data on the rate of root growth, the stages of mitosis, and the number of mitoses in control and BL-treated groups of onions. Low doses of BL (0.005 ppm) nearly doubled the mean root length and the number of mitoses over that of controls. Intermediate doses of BL (0.05 ppm) also produced mean root lengths and number of mitoses that were significantly greater than those of the controls. The highest dose of BL (0.5 ppm) produced mean root lengths and number of mitoses that were less than control values, but the differences were not statistically significant. Examination of longitudinally sectioned root tips produced relatively similar results. This study confirms the suppositions of previous authors who have claimed that exogenously applied BL can increase the number of mitoses in plants, but failed to show cytogenetic data. This is the first report detailing the effects of BL on chromosomes and the cell cycle.


Sujet(s)
Cholestanols/pharmacologie , Mitose/effets des médicaments et des substances chimiques , Oignons/effets des médicaments et des substances chimiques , Facteur de croissance végétal/pharmacologie , Racines de plante/croissance et développement , Stéroïdes hétérocycliques/pharmacologie , Brassinostéroïdes , Index mitotique , Oignons/croissance et développement , Racines de plante/effets des médicaments et des substances chimiques
3.
Genet. mol. res. (Online) ; Genet. mol. res. (Online);6(1): 50-58, 2007. ilus, tab
Article de Anglais | LILACS | ID: lil-456750

RÉSUMÉ

The purpose of the present study was to determine the effects of the steroidal plant hormone, 24-epibrassinolide (BL), on the mitotic index and growth of onion (Allium cepa) root tips. The classical Allium test was used to gather and quantify data on the rate of root growth, the stages of mitosis, and the number of mitoses in control and BL-treated groups of onions. Low doses of BL (0.005 ppm) nearly doubled the mean root length and the number of mitoses over that of controls. Intermediate doses of BL (0.05 ppm) also produced mean root lengths and number of mitoses that were significantly greater than those of the controls. The highest dose of BL (0.5 ppm) produced mean root lengths and number of mitoses that were less than control values, but the differences were not statistically significant. Examination of longitudinally sectioned root tips produced relatively similar results. This study confirms the suppositions of previous authors who have claimed that exogenously applied BL can increase the number of mitoses in plants, but failed to show cytogenetic data. This is the first report detailing the effects of BL on chromosomes and the cell cycle.


Sujet(s)
Cholestanols/pharmacologie , Mitose/effets des médicaments et des substances chimiques , Oignons/croissance et développement , Facteur de croissance végétal/pharmacologie , Racines de plante/croissance et développement , Stéroïdes hétérocycliques/pharmacologie , Index mitotique , Oignons/effets des médicaments et des substances chimiques , Racines de plante/effets des médicaments et des substances chimiques
4.
Br J Addict ; 87(1): 91-102, 1992 Jan.
Article de Anglais | MEDLINE | ID: mdl-1543944

RÉSUMÉ

A 6-year follow-up of a cohort of male and female white collar workers in whom there was baseline information on alcohol consumption and access to data on sickness absence, promotion and labour turnover, revealed that even moderate alcohol and consumption in this population was associated with social costs for the employer and the employee, particularly in terms of sickness absence. The longitudinal examination of consumption in this study suggests that early intervention in a drinking career may reduce alcohol consumption and consequently avoid years of morbidity and sickness absence, as well as having a favourable influence on promotion prospects and labour turnover.


Sujet(s)
Alcoolisme/épidémiologie , Classe sociale , Adulte , Études de cohortes , Études transversales , Angleterre/épidémiologie , Femelle , Études de suivi , Humains , Incidence , Études longitudinales , Mâle
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE